X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Cadila Healthcare with IPCA Labs - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

CADILA HEALTHCARE vs IPCA LABS - Comparison Results

CADILA HEALTHCARE    Change

Cadila Healthcare is one of the leading players in the Indian pharma market having a presence in both the domestic and international markets. In the international markets, the company had adopted the strategy of competing directly in the generics mar... More

IPCA LABS 
   Change

Ipca Laboratories is an integrated pharmaceutical company with presence in intermediates, APIs and formulations. The company has a strong focus on exports, catering to the US, Europe and the semi-regulated markets of the CIS, Africa and Asia. The com... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    CADILA HEALTHCARE IPCA LABS CADILA HEALTHCARE/
IPCA LABS
 
P/E (TTM) x 35.1 27.5 127.9% View Chart
P/BV x 9.0 2.1 429.6% View Chart
Dividend Yield % 0.7 0.2 277.2%  

Financials

 CADILA HEALTHCARE   IPCA LABS
EQUITY SHARE DATA
    CADILA HEALTHCARE
Mar-16
IPCA LABS
Mar-17
CADILA HEALTHCARE/
IPCA LABS
5-Yr Chart
Click to enlarge
High Rs454643 70.7%   
Low Rs305503 60.6%   
Sales per share (Unadj.) Rs96.1254.4 37.8%  
Earnings per share (Unadj.) Rs14.916.1 92.6%  
Cash flow per share (Unadj.) Rs17.829.8 59.9%  
Dividends per share (Unadj.) Rs3.201.00 320.0%  
Dividend yield (eoy) %0.80.2 483.1%  
Book value per share (Unadj.) Rs52.3194.6 26.9%  
Shares outstanding (eoy) m1,023.74126.20 811.2%   
Bonus/Rights/Conversions FV5:1--  
Price / Sales ratio x3.92.3 175.4%   
Avg P/E ratio x25.535.7 71.6%  
P/CF ratio (eoy) x21.319.2 110.6%  
Price / Book Value ratio x7.32.9 246.5%  
Dividend payout %21.56.2 345.8%   
Avg Mkt Cap Rs m388,45872,300 537.3%   
No. of employees `00015.413.3 116.1%   
Total wages/salary Rs m13,3176,960 191.3%   
Avg. sales/employee Rs Th6,371.12,413.5 264.0%   
Avg. wages/employee Rs Th862.4523.2 164.8%   
Avg. net profit/employee Rs Th986.1152.4 646.8%   
INCOME DATA
Net Sales Rs m98,37632,106 306.4%  
Other income Rs m941226 416.9%   
Total revenues Rs m99,31732,332 307.2%   
Gross profit Rs m23,8294,448 535.7%  
Depreciation Rs m3,0221,730 174.7%   
Interest Rs m486241 201.8%   
Profit before tax Rs m21,2622,703 786.5%   
Minority Interest Rs m-3000-   
Prior Period Items Rs m50-   
Extraordinary Inc (Exp) Rs m-250-   
Tax Rs m5,716675 846.6%   
Profit after tax Rs m15,2262,028 750.8%  
Gross profit margin %24.213.9 174.8%  
Effective tax rate %26.925.0 107.6%   
Net profit margin %15.56.3 245.0%  
BALANCE SHEET DATA
Current assets Rs m44,37617,340 255.9%   
Current liabilities Rs m34,0719,559 356.4%   
Net working cap to sales %10.524.2 43.2%  
Current ratio x1.31.8 71.8%  
Inventory Days Days54100 53.7%  
Debtors Days Days6257 109.6%  
Net fixed assets Rs m47,89620,779 230.5%   
Share capital Rs m1,024252 405.7%   
"Free" reserves Rs m48,74624,499 199.0%   
Net worth Rs m53,51924,553 218.0%   
Long term debt Rs m8,9643,517 254.8%   
Total assets Rs m100,16339,595 253.0%  
Interest coverage x44.712.2 366.0%   
Debt to equity ratio x0.20.1 116.9%  
Sales to assets ratio x1.00.8 121.1%   
Return on assets %15.75.7 273.8%  
Return on equity %28.48.3 344.4%  
Return on capital %34.310.5 327.0%  
Exports to sales %45.348.6 93.1%   
Imports to sales %5.914.2 41.7%   
Exports (fob) Rs m44,53715,617 285.2%   
Imports (cif) Rs m5,8384,571 127.7%   
Fx inflow Rs m44,88115,617 287.4%   
Fx outflow Rs m9,0695,828 155.6%   
Net fx Rs m35,8129,790 365.8%   
CASH FLOW
From Operations Rs m19,9382,764 721.3%  
From Investments Rs m-9,039-1,432 631.3%  
From Financial Activity Rs m-9,527-1,591 598.7%  
Net Cashflow Rs m1,372-259 -530.1%  

Share Holding

Indian Promoters % 74.8 45.9 163.0%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 8.3 11.4 72.8%  
FIIs % 5.9 25.3 23.3%  
ADR/GDR % 0.0 0.0 -  
Free float % 11.0 17.4 63.2%  
Shareholders   44,069 36,892 119.5%  
Pledged promoter(s) holding % 0.0 2.1 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare CADILA HEALTHCARE With:   STRIDES SHASUN LTD  AJANTA PHARMA  ALEMBIC LTD  DR. DATSONS LABS  ELDER PHARMA  

Compare CADILA HEALTHCARE With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Post Noon Sell-Off; Infosys Falls 5.4%(Closing)

Share markets in India witnessed a sharp fall in the final minutes of trade. At the closing bell, the BSE Sensex closed lower by 266 points. While, the NSE Nifty finished lower by 83 points.

Related Views on News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

A 'Backdoor' to Multibaggers: It's Like Investing in Asian Paints Ten Years Ago(The 5 Minute Wrapup)

Aug 10, 2017

Don't miss these proxy bets on growing companies or in a few years you will be looking back with regret.

The Most Profitable Investment in the History of the World(Vivek Kaul's Diary)

Aug 8, 2017

'Yes, it looks like a bubble. And, yes, it's like buying a lottery ticket. But there's something happening that has never happened before. It's an evolutionary leap in money itself.'

Should You Invest In Bharat-22 ETF? Know Here...(Outside View)

Aug 8, 2017

Bharat-22 is one of the most diverse ETFs offered so far by the Government. Know here if you should invest...

Signs of Life in the India VIX(Daily Profit Hunter)

Aug 12, 2017

The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

Bitcoin Continues Stellar Rise(Chart Of The Day)

Aug 10, 2017

Bitcoin hits an all-time high, is there more upside left?

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

CADILA HEALTHCARE SHARE PRICE


Aug 21, 2017 (Close)

TRACK CADILA HEALTHCARE

  • Track your investment in CADILA HEALTHCARE with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON CADILA HEALTHCARE

CADILA HEALTHCARE 5-YR ANALYSIS

COMPARE CADILA HEALTHCARE WITH

MARKET STATS